Michael P. Dube - Jan 3, 2025 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
VP, Chief Accounting Officer
Signature
James Basta, attorney-in-fact
Stock symbol
NTLA
Transactions as of
Jan 3, 2025
Transactions value $
-$16,711
Form type
4
Date filed
1/7/2025, 05:23 PM
Previous filing
Oct 4, 2024
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale -$16.7K -1.37K -2.92% $12.18 45.6K Jan 3, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.